PBI-6DNJ
PBI-6DNJ is a potent, orally bioavailable multivalent glycosidase inhibitor with a Ki of 0.14 μM against murine α-glucosidase. It demonstrates significant hypoglycemic effects in vivo, making it a valuable research tool for studying type 2 diabetes mechanisms and potential therapeutic strategies.
Product Specifications
Field of Research
Metabolism Research
Molecular Formula
C120H146N26O36
Molecular Weight
2528.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7062308 Inquire
Recombinant Rhizobium radiobacter Protein virB3 (virB3), partial
Sign In for Pricing
View Details 
